ABC News @ABC
Drugs such as Ozempic, Mounjaro and Wegovy have been touted as breakthrough drugs for patients looking to lose weight. But with the increased demand have come reports of access problems for diabetic patients with dire health issues. https://t.co/GjZ8y3lfE7 — PolitiTweet.org